Baby Safety / Compounds / Dihydrosafrole

Is Dihydrosafrole safe for babies and kids?

Low risk for kids

(Babies-specific data is limited; this page draws from human adult context.) Dihydrosafrole poses low risk to adults under normal use conditions.

What is dihydrosafrole?

The IUPAC name is 5-allyl-1,3-benzodioxole.

Also known as: 5-allyl-1,3-benzodioxole, 5-Propyl-1,3-benzodioxole, Safrole, dihydro-, 1,3-Benzodioxole, 5-propyl-.

IUPAC name
5-allyl-1,3-benzodioxole
CAS number
94-58-6
Molecular formula
C10H12O2
Molecular weight
164.2 g/mol
SMILES
CCCC1=CC2=C(C=C1)OCO2
PubChem CID
7197

Risk for babies

Low risk

Dihydrosafrole poses low risk to adults under normal use conditions.

Regulatory consensus

2 regulatory and scientific bodies have classified Dihydrosafrole. The classifications differ — that's the data.

AgencyYearClassificationNotes
EU——EU Cosmetics Regulation (EC) No 1223/2009 - extended allergen declaration requirement
IFRA——IFRA Standards on Fragrance Materials

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter dihydrosafrole

  • Perfume
  • Personal Care
  • Fragrance Mixtures

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Dihydrosafrole:

  • Fragrance-free product formulations
    Trade-offs: Eliminates allergen risk entirely; consumer acceptance varies (some associate scent with cleanliness/efficacy); growing market segment; regulatory advantage in EU (no IFRA compliance needed).
    Relative cost: Lower (ingredient elimination)
  • Essential oil-free synthetic fragrance blends with established safety profiles
    Trade-offs: Allows scent without specific natural allergens; synthetic molecules can be individually safety-tested; some synthetics have their own sensitization profiles; cost comparable to natural blends.
    Relative cost: Lower (ingredient elimination)
  • Encapsulated fragrance technologies (reduced dermal contact)
    Trade-offs: Reduces dermal contact by 60-90% via polymer shell release mechanism; higher formulation cost; may alter scent perception (delayed release); shell material itself requires safety assessment.
    Relative cost: 1.2-2×
  • Naturally-derived isolates at IFRA-compliant concentrations
    Trade-offs: Alternative fragrance ingredient; individual safety profile should be assessed per IFRA standards; sensitization potential varies by compound; patch testing recommended for sensitive individuals.
    Relative cost: 2-5× conventional

Frequently asked questions

No FAQ entries generated.

See Dihydrosafrole in the baby app

Look up products containing dihydrosafrole, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. ATSDR Toxicological Profile — CAS 94-58-6 — reference

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →